Denali Therapeutics Inc. buy BiotechBee
Start price
08.09.24
/
70%
€23.00
Target price
30.05.27
€31.00
Performance (%)
-4.35%
End price
14.12.24
€22.00
Summary
This prediction ended on 14.12.24 with a price of €22.00. With a performance of -4.35%, the BUY prediction by BiotechBee finished with a loss. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Denali Therapeutics Inc. | -7.821% | -7.821% | 47.717% |
| iShares Core DAX® | 3,02 % | 2,20 % | 14,66 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % | 31,41 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % | 49,42 % |
| iShares S&P 500 | 2,64 % | 1,01 % | 25,12 % |
According to BiotechBee what are the pros and cons of Denali Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year